First Time Loading...

Abbvie Inc
NYSE:ABBV

Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
NYSE:ABBV
Watchlist
Price: 159.62 USD -4.58% Market Closed
Updated: Apr 27, 2024

Abbvie Inc
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Abbvie Inc
Net Change in Cash Peer Comparison

Comparables:
GILD
AMGN
MRNA
VRTX
REGN

Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
Abbvie Inc
NYSE:ABBV
Net Change in Cash
$3.6B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
0%
Gilead Sciences Inc
NASDAQ:GILD
Net Change in Cash
$673m
CAGR 3-Years
N/A
CAGR 5-Years
-42%
CAGR 10-Years
8%
Amgen Inc
NASDAQ:AMGN
Net Change in Cash
$3.3B
CAGR 3-Years
144%
CAGR 5-Years
1%
CAGR 10-Years
20%
Moderna Inc
NASDAQ:MRNA
Net Change in Cash
-$289m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Net Change in Cash
-$139.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Net Change in Cash
-$381.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Abbvie Inc's Net Change in Cash?
Net Change in Cash
3.6B USD

Based on the financial report for Dec 31, 2023, Abbvie Inc's Net Change in Cash amounts to 3.6B USD.

What is Abbvie Inc's Net Change in Cash growth rate?
Net Change in Cash CAGR 10Y
0%